Cosmos Health (COSM) FCF Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly FCF Margin came in at 9.39% in Q2 2026, down 103.0% on a YoY basis from 312.84% in Q2 2025, and down 56.01% quarter-over-quarter from 6.02% in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) FCF Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported FCF Margin for 12 consecutive years, with 9.39% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 103.0% year-over-year to 9.39%; the trailing twelve-month figure through Jun 2026 stood at 13.47% (down 471.0% YoY), and the FY2025 full-year result was 13.03%, up 192.0% from the prior year.
- FCF Margin slipped to 9.39% in Q2 2026 per COSM's latest filing, from 6.02% in the prior quarter.
- Across five years, FCF Margin topped out at 5.71% in Q4 2023 and bottomed at 85.93% in Q4 2022.
- Historically, FCF Margin has averaged 21.07% across 5 years, with a median of 13.6% in 2022.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 7599 bps in 2022, then soared 9164 bps in 2023.
- Over 5 years, FCF Margin stood at 85.93% in 2022, then jumped by 107 bps to 5.71% in 2023, then sank by 581 bps to 27.46% in 2024, then advanced by 15 bps to 23.37% in 2025, then soared by 60 bps to 9.39% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 9.39%, 6.02%, and 23.37% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 20.79% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 14.76% |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 20.15% |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -9.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.39% |
| Mar 31, 2026 | -6.02% |
| Dec 31, 2025 | -23.37% |
| Sep 30, 2025 | -14.42% |
| Jun 30, 2025 | -8.36% |
| Mar 31, 2025 | -1.45% |
| Dec 31, 2024 | -27.46% |
| Sep 30, 2024 | 4.12% |
| Jun 30, 2024 | -9.43% |
| Mar 31, 2024 | -23.96% |
| Dec 31, 2023 | 5.71% |
| Sep 30, 2023 | -35.40% |
| Jun 30, 2023 | -56.16% |
| Mar 31, 2023 | -51.58% |
| Dec 31, 2022 | -85.93% |
| Sep 30, 2022 | -12.77% |
| Jun 30, 2022 | -5.40% |
| Mar 31, 2022 | -17.91% |
| Dec 31, 2021 | -9.94% |
| Sep 30, 2021 | -26.03% |